Insulin degludec Subcutaneous and Zoledronic Acid (Bone Health)
Determining the interaction of Insulin degludec Subcutaneous and Zoledronic Acid (Bone Health) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Zoledronic Acid (Zometa)
- Insulin degludec Subcutaneous-Zoledronic Acid Injection
- Insulin degludec Subcutaneous-Zoledronic Acid Injection Concentrate
- Insulin degludec Subcutaneous-Zoledronic acid Intravenous
- Insulin degludec Subcutaneous-Zoledronic Acid IV
- Insulin degludec Subcutaneous-Zolgensma
- Zoledronic Acid (Bone Health)-Insulin detemir
- Zoledronic Acid (Bone Health)-Insulin Detemir (Cartridges and Prefilled Syringes)
- Zoledronic Acid (Bone Health)-Insulin Detemir (Vials)
- Zoledronic Acid (Bone Health)-Insulin detemir Subcutaneous
- Zoledronic Acid (Bone Health)-Insulin glargine
- Zoledronic Acid (Bone Health)-Insulin Glargine (U-100) Cartridge Systems and Pens